Athenex : Announces Completion of Sale of Dunkirk Manufacturing Facility - Form 8-K

Athenex Announces Completion of Sale of Dunkirk Manufacturing Facility


Buffalo, N.Y., FEBRUARY 15, 2022 - Athenex, Inc., a global biopharmaceutical company... | February 15, 2022

Related Keywords

New York ,United States ,Jeffrey Yordon ,Exchange Commission On ,Immunitybio Inc ,Athenex Pharmaceutical Division ,Nasdaq ,Athenex Inc ,Athenex Announces Completion ,Dunkirk Manufacturing ,Chief Operating Officer ,President Athenex Pharmaceutical Division ,Exchange Commission ,Oncology Innovation Platform ,Commercial Platform ,Global Supply Chain ,Athenex ,Nc Stock Exchange ,News ,Information ,Press Release ,Nnounces ,Completion ,F ,Sale ,Dunkirk ,Manufacturing ,February ,022 ,Lobal ,Iopharmaceutical Atnx Us04685n1037 ,